Revenue Update on Sientra Inc(NASDAQ:SIEN)

Sientra Inc(NASDAQ:SIEN) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 9, 2016. Company reported revenue of $6.24M. Analysts estimated a revenue of $4.80M. Earnings per share were $-0.56. Analysts had estimated an EPS of $-0.51.

Sientra Inc (SIEN) shares turned negative on Wednesdays trading session with the shares closing down -0.19 points or -2.33% at a volume of 1,40,068. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $8.172. The peak price level was also seen at $8.172 while the days lowest was $7.92. Finally the shares closed at $7.98. The 52-week high of the shares is $25 while the 52-week low is $2.7799. According to the latest information available, the market cap of the company is $145 M.

Sientra Inc. is a medical aesthetics company. The company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures which it offers in over 150 variations of shapes sizes and textures. The Company sells its breast implants and breast tissue expanders or breast products to plastic surgeons. The Company offers a range of breast implants including anatomically-shaped textured round textured and round smooth. It also offers a line of breast tissue expanders most of which are marketed as ACX in 25 different shapes and sizes that include single and double chamber tissue expanders. In addition it offers a range of other aesthetic products including: body contouring and other implants; silicone elastomer oval carving blocks; scar management specialty products; temporary single-use saline-filled breast sizers and non-breast tissue expanders.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *